| AstraZeneca (AZN) |
GB |
$209.551B |
15.64 |
| Amgen (AMGN) |
US |
$142.955B |
12.81 |
| Gilead Sciences (GILD) |
US |
$120.549B |
12.52 |
| Vertex Pharmaceuticals (VRTX) |
US |
$109.136B |
0.00 |
| Bristol Myers Squibb (BMY) |
US |
$94.530B |
6.33 |
| GSK (GSK) |
GB |
$75.556B |
8.98 |
| CSL (CSLLY) |
AU |
$74.278B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
US |
$56.982B |
13.83 |
| Argenex SE (ARGX) |
NL |
$33.561B |
91.61 |
| Alnylam Pharmaceuticals (ALNY) |
US |
$32.747B |
0.00 |
| BeiGene (ONC) |
KY |
$22.978B |
0.00 |
| BioNTech SE (BNTX) |
DE |
$22.301B |
0.00 |
| Royalty Pharma (RPRX) |
US |
$19.109B |
7.87 |
| Biogen (BIIB) |
US |
$17.315B |
7.47 |
| Genmab (GNMSF) |
DK |
$12.761B |
13.05 |
| Genmab (GMAB) |
DK |
$12.414B |
13.93 |
| Illumina (ILMN) |
US |
$11.990B |
22.75 |
| Insmed (INSM) |
US |
$11.854B |
0.00 |
| Incyte (INCY) |
US |
$11.417B |
86.74 |
| BioMarin Pharmaceutical (BMRN) |
US |
$11.288B |
18.34 |
| Swedish Orphan Biovitrum (BIOVF) |
SE |
$10.858B |
27.73 |
| Exelixis (EXEL) |
US |
$9.968B |
20.67 |
| Exact Sciences (EXAS) |
US |
$9.739B |
0.00 |
| Moderna (MRNA) |
US |
$9.378B |
0.00 |
| QIAGEN (QGEN) |
NL |
$9.305B |
18.10 |
| Ascendis Pharma (ASND) |
DK |
$9.222B |
0.00 |
| Halozyme Therapeutics (HALO) |
US |
$8.117B |
15.53 |
| Bio-Techne Corp (TECH) |
US |
$7.829B |
29.20 |
| Roivant Sciences (ROIV) |
GB |
$7.592B |
0.00 |
| Revolution Medicines (RVMD) |
US |
$7.529B |
0.00 |
| Repligen (RGEN) |
US |
$6.924B |
77.51 |
| Bio-Rad Laboratories (BIO.B) |
US |
$6.566B |
22.20 |
| Blueprint Medicines (BPMC) |
US |
$6.275B |
0.00 |
| Jazz Pharmaceuticals (JAZZ) |
IE |
$6.026B |
5.81 |
| Legend Biotech (LEGN) |
US |
$5.836B |
0.00 |
| Telix Pharmaceuticals (TLX) |
AU |
$5.805B |
0.00 |
| Verona Pharma American Depositary Share (VRNA) |
GB |
$5.381B |
0.00 |
| TG Therapeutics (TGTX) |
US |
$5.341B |
140.17 |
| Axsome Therapeutics (AXSM) |
US |
$5.306B |
0.00 |
| Guardant Health (GH) |
US |
$5.169B |
0.00 |
| Nuvalent (NUVL) |
US |
$5.001B |
0.00 |
| Alkermes (ALKS) |
IE |
$4.968B |
13.33 |
| Regencell Bioscience Holdings (RGC) |
HK |
$4.763B |
0.00 |
| ADMA Biologics Inc (ADMA) |
US |
$4.748B |
35.68 |
| Zealand Pharma (ZLDPF) |
DK |
$4.573B |
0.00 |
| Vaxcyte (PCVX) |
US |
$4.020B |
0.00 |
| Krystal Biotech (KRYS) |
US |
$3.820B |
29.44 |
| Cytokinetics (CYTK) |
US |
$3.785B |
0.00 |
| Rhythm Pharmaceuticals (RYTM) |
US |
$3.651B |
0.00 |
| Sarepta Therapeutics (SRPT) |
US |
$3.565B |
0.00 |
| PTC Therapeutics (PTCT) |
US |
$3.506B |
6.10 |
| SpringWorks Therapeutics (SWTX) |
US |
$3.469B |
0.00 |
| Avidity Biosciences (RNA) |
US |
$3.359B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
US |
$3.319B |
0.00 |
| Zai Lab (ZLAB) |
CN |
$3.226B |
0.00 |
| Akero Therapeutics (AKRO) |
US |
$3.175B |
0.00 |
| Arcellx (ACLX) |
US |
$3.171B |
0.00 |
| Viking Therapeutics (VKTX) |
US |
$3.094B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
CH |
$3.076B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
US |
$2.919B |
25.65 |
| Alvotech (ALVO) |
LU |
$2.918B |
16.69 |
| Scholar Rock Holding (SRRK) |
US |
$2.909B |
0.00 |
| Merus (MRUS) |
NL |
$2.831B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
CA |
$2.682B |
0.00 |
| Protagonist Therapeutics (PTGX) |
US |
$2.663B |
57.29 |
| Metsera (MTSR) |
US |
$2.508B |
0.00 |
| HUTCHMED (China) (HCM) |
HK |
$2.477B |
0.00 |
| MoonLake Immunotherapeutics (MLTX) |
CH |
$2.463B |
0.00 |
| Immunovant (IMVT) |
US |
$2.381B |
0.00 |
| Mirum Pharmaceuticals (MIRM) |
US |
$2.193B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
US |
$2.174B |
0.00 |
| Ascentage Pharma Group - (AAPG) |
CN |
$2.117B |
0.00 |
| Vericel (VCEL) |
US |
$2.101B |
1391.00 |
| Denali Therapeutics (DNLI) |
US |
$2.088B |
0.00 |
| Biohaven (BHVN) |
US |
$2.066B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
US |
$2.014B |
0.00 |
| Kymera Therapeutics (KYMR) |
US |
$1.958B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
US |
$1.955B |
13.00 |
| Bavarian Nordic (BVNRY) |
DK |
$1.952B |
10.31 |
| Belite Bio (BLTE) |
US |
$1.945B |
0.00 |
| Certara (CERT) |
US |
$1.944B |
36.30 |
| NovoCure (NVCR) |
JE |
$1.938B |
0.00 |
| Kiniksa Pharmaceuticals (KNSA) |
GB |
$1.899B |
0.00 |
| Tarsus Pharmaceuticals (TARS) |
US |
$1.881B |
0.00 |
| Twist Bioscience (TWST) |
US |
$1.847B |
0.00 |
| Amicus Therapeutics (FOLD) |
US |
$1.841B |
199.33 |
| ImmunityBio (IBRX) |
US |
$1.827B |
0.00 |
| CG Oncology (CGON) |
US |
$1.810B |
0.00 |
| Arrowhead Pharmaceuticals (ARWR) |
US |
$1.789B |
0.00 |
| Travere Therapeutics (TVTX) |
US |
$1.778B |
0.00 |
| Beam Therapeutics (BEAM) |
US |
$1.751B |
0.00 |
| Apogee Therapeutics (APGE) |
US |
$1.674B |
0.00 |
| Arcutis Biotherapeutics (ARQT) |
US |
$1.613B |
0.00 |
| Agios Pharmaceuticals (AGIO) |
US |
$1.582B |
0.00 |
| Edgewise Therapeutics (EWTX) |
US |
$1.534B |
0.00 |
| Disc Medicine (IRON) |
US |
$1.529B |
0.00 |
| IDEAYA Biosciences (IDYA) |
US |
$1.526B |
0.00 |
| Janux Therapeutics (JANX) |
US |
$1.513B |
0.00 |
| Structure Therapeutics (GPCR) |
US |
$1.466B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
US |
$1.444B |
14.80 |
| Immunocore Holdings (IMCR) |
GB |
$1.422B |
0.00 |
| Mesoblast (MESO) |
AU |
$1.402B |
0.00 |
| MannKind (MNKD) |
US |
$1.386B |
28.50 |
| Vera Therapeutics (VERA) |
US |
$1.384B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
US |
$1.372B |
0.00 |
| Liquidia Technologies (LQDA) |
US |
$1.304B |
0.00 |
| GRAIL (GRAL) |
US |
$1.242B |
0.00 |
| Celldex Therapeutics (CLDX) |
US |
$1.217B |
0.00 |
| Pacira BioSciences (PCRX) |
US |
$1.163B |
11.07 |
| Dynavax Technologies (DVAX) |
US |
$1.130B |
67.21 |
| 89BIO (ETNB) |
US |
$1.124B |
0.00 |
| BGM Group (BGM) |
CN |
$1.072B |
0.00 |
| MiMedx (MDXG) |
US |
$1.041B |
25.18 |
| NeoGenomics (NEO) |
US |
$1.036B |
0.00 |
| WAVE Life Sciences (WVE) |
SG |
$1.015B |
0.00 |
| Viridian Therapeutics (VRDN) |
US |
$1.011B |
0.00 |
| Novavax (NVAX) |
US |
$0.968B |
2.25 |
| Mineralys Therapeutics (MLYS) |
US |
$0.950B |
0.00 |
| Anbio Biotechnology (NNNN) |
DE |
$0.925B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
US |
$0.921B |
0.00 |
| Gyre Therapeutics (GYRE) |
US |
$0.893B |
238.25 |
| Pharvaris (PHVS) |
NL |
$0.888B |
0.00 |
| Arcus Biosciences (RCUS) |
US |
$0.877B |
0.00 |
| Spyre Therapeutics (SYRE) |
US |
$0.850B |
0.00 |
| Intellia Therapeutics (NTLA) |
US |
$0.841B |
0.00 |
| Oculis Holding AG (OCS) |
CH |
$0.811B |
0.00 |
| CorMedix Inc (CRMD) |
US |
$0.791B |
53.00 |
| Zymeworks (ZYME) |
US |
$0.787B |
0.00 |
| Praxis Precision Medicines (PRAX) |
US |
$0.781B |
0.00 |
| CureVac (CVAC) |
DE |
$0.778B |
4.23 |
| Geron (GERN) |
US |
$0.752B |
0.00 |
| Rocket Pharmaceuticals (RCKT) |
US |
$0.746B |
0.00 |
| LENZ Therapeutics (LENZ) |
US |
$0.741B |
0.00 |
| Nurix Therapeutics (NRIX) |
US |
$0.724B |
0.00 |
| Nuvation Bio (NUVB) |
US |
$0.708B |
0.00 |
| Bicara Therapeutics (BCAX) |
US |
$0.707B |
0.00 |
| Niagen Bioscience (NAGE) |
US |
$0.705B |
99.44 |
| Anavex Life Sciences (AVXL) |
US |
$0.704B |
0.00 |
| Vir Biotechnology (VIR) |
US |
$0.703B |
0.00 |
| UniQure (QURE) |
NL |
$0.701B |
0.00 |
| ArriVent BioPharma (AVBP) |
US |
$0.686B |
0.00 |
| Pharming Group (PHAR) |
NL |
$0.682B |
0.00 |
| Trevi Therapeutics (TRVI) |
US |
$0.659B |
0.00 |
| Day One Biopharmaceuticals (DAWN) |
US |
$0.654B |
0.00 |
| Immunome (IMNM) |
US |
$0.649B |
0.00 |
| Sinovac Biotech (SVA) |
CN |
$0.645B |
0.00 |
| Dianthus Therapeutics (DNTH) |
US |
$0.629B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
CH |
$0.626B |
0.00 |
| Arbutus Biopharma (ABUS) |
US |
$0.618B |
0.00 |
| Pharming Group (PHGUF) |
NL |
$0.613B |
0.00 |
| AbCellera Biologics (ABCL) |
CA |
$0.606B |
0.00 |
| Replimune (REPL) |
US |
$0.594B |
0.00 |
| Iovance Biotherapeutics (IOVA) |
US |
$0.584B |
0.00 |
| Bicycle Therapeutics (BCYC) |
GB |
$0.578B |
0.00 |
| AnaptysBio (ANAB) |
US |
$0.576B |
0.00 |
| Fortrea Holdings (FTRE) |
US |
$0.557B |
18.09 |
| Keros Therapeutics (KROS) |
US |
$0.554B |
0.00 |
| Cogent Biosciences (COGT) |
US |
$0.548B |
0.00 |
| Sionna Therapeutics (SION) |
US |
$0.544B |
0.00 |
| GH Research (GHRS) |
IE |
$0.540B |
0.00 |
| Tyra Biosciences (TYRA) |
US |
$0.536B |
0.00 |
| Opthea (OPT) |
AU |
$0.525B |
0.00 |
| Immatics (IMTX) |
DE |
$0.515B |
30.29 |
| Stoke Therapeutics (STOK) |
US |
$0.511B |
0.00 |
| Kura Oncology (KURA) |
US |
$0.499B |
0.00 |
| Zhengye Biotechnology Holding (ZYBT) |
CN |
$0.486B |
0.00 |
| Castle Biosciences (CSTL) |
US |
$0.485B |
32.91 |
| Arvinas (ARVN) |
US |
$0.482B |
0.00 |
| Urogen Pharma (URGN) |
US |
$0.479B |
0.00 |
| Upstream Bio (UPB) |
US |
$0.474B |
0.00 |
| Mind Medicine (MindMed) (MNMD) |
US |
$0.464B |
0.00 |
| Ginkgo Bioworks Holdings (DNA) |
US |
$0.450B |
0.00 |
| Cullinan Therapeutics (CGEM) |
US |
$0.445B |
0.00 |
| MeiraGTx Holdings (MGTX) |
US |
$0.433B |
0.00 |
| Abivax SA (ABVX) |
FR |
$0.426B |
0.00 |
| Maze Therapeutics (MAZE) |
US |
$0.421B |
0.00 |
| Oxford BioMedica (OXBDF) |
GB |
$0.416B |
0.00 |
| Sage Therapeutics (SAGE) |
US |
$0.411B |
0.00 |
| Sana Biotechnology (SANA) |
US |
$0.410B |
0.00 |
| PureTech Health (PRTC) |
US |
$0.403B |
0.00 |
| Prothena (PRTA) |
IE |
$0.400B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
US |
$0.400B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
US |
$0.396B |
0.00 |
| Kamada (KMDA) |
IL |
$0.395B |
26.46 |
| Erasca (ERAS) |
US |
$0.394B |
0.00 |
| Precigen (PGEN) |
US |
$0.393B |
0.00 |
| Celcuity (CELC) |
US |
$0.384B |
0.00 |
| Mereo BioPharma Group - (MREO) |
GB |
$0.383B |
0.00 |
| Zenas BioPharma (ZBIO) |
US |
$0.379B |
0.00 |
| REGENXBIO (RGNX) |
US |
$0.377B |
0.00 |
| Rapport Therapeutics (RAPP) |
US |
$0.374B |
0.00 |
| Alpha Teknova (TKNO) |
US |
$0.372B |
0.00 |
| MBX Biosciences (MBX) |
US |
$0.371B |
0.00 |
| Cytek Biosciences (CTKB) |
US |
$0.370B |
0.00 |
| Verastem (VSTM) |
US |
$0.369B |
0.00 |
| Tectonic Therapeutic (TECX) |
US |
$0.369B |
0.00 |
| Oric Pharmaceuticals (ORIC) |
US |
$0.361B |
0.00 |
| Myriad Genetics (MYGN) |
US |
$0.359B |
0.00 |
| Autolus Therapeutics (AUTL) |
GB |
$0.351B |
0.00 |
| Absci (ABSI) |
US |
$0.351B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
US |
$0.349B |
0.00 |
| Benitec Biopharma (BNTC) |
US |
$0.320B |
0.00 |
| Entrada Therapeutics (TRDA) |
US |
$0.318B |
10.35 |
| Olema Pharmaceuticals (OLMA) |
US |
$0.314B |
0.00 |
| Emergent Biosolutions (EBS) |
US |
$0.307B |
0.00 |
| Corvus Pharmaceuticals (CRVS) |
US |
$0.302B |
0.00 |
| Septerna (SEPN) |
US |
$0.298B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
US |
$0.298B |
0.00 |
| ATyr Pharma (ATYR) |
US |
$0.292B |
0.00 |
| Fulcrum Therapeutics (FULC) |
US |
$0.290B |
0.00 |
| XOMA Royalty (XOMA) |
US |
$0.289B |
0.00 |
| Prima BioMed (IMMP) |
AU |
$0.270B |
0.00 |
| DBV Technologies S.A (DBVT) |
FR |
$0.269B |
0.00 |
| 2seventy Bio (TSVT) |
US |
$0.266B |
0.00 |
| Terns Pharmaceuticals (TERN) |
US |
$0.266B |
0.00 |
| Aura Biosciences (AURA) |
US |
$0.263B |
0.00 |
| Lifecore Biomedical (LFCR) |
US |
$0.258B |
0.00 |
| Abeona Therapeutics (ABEO) |
US |
$0.257B |
0.00 |
| Cartesian Therapeutics (RNAC) |
US |
$0.257B |
0.00 |
| ITeos Therapeutics (ITOS) |
US |
$0.255B |
0.00 |
| Allogene Therapeutics (ALLO) |
US |
$0.254B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
US |
$0.253B |
0.00 |
| BioStem Technologies (BSEM) |
|
$0.252B |
10.07 |
| Gossamer Bio (GOSS) |
US |
$0.252B |
0.00 |
| Compass Therapeutics (CMPX) |
US |
$0.252B |
0.00 |
| Monte Rosa Therapeutics (GLUE) |
US |
$0.252B |
51.12 |
| Palvella Therapeutics (PVLA) |
US |
$0.251B |
0.00 |
| MaxCyte (MXCT) |
US |
$0.250B |
0.00 |
| Monopar Therapeutics (MNPR) |
US |
$0.241B |
0.00 |
| Astria Therapeutics (ATXS) |
US |
$0.239B |
0.00 |
| ACELYRIN, INC (SLRN) |
US |
$0.238B |
0.00 |
| Alumis (ALMS) |
US |
$0.238B |
0.00 |
| Candel Therapeutics (CADL) |
US |
$0.237B |
0.00 |
| Foghorn Therapeutics (FHTX) |
US |
$0.234B |
0.00 |
| Cidara Therapeutics (CDTX) |
US |
$0.234B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
US |
$0.233B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
US |
$0.233B |
0.00 |
| Third Harmonic Bio (THRD) |
US |
$0.232B |
0.00 |
| Bright Minds Biosciences (DRUG) |
US |
$0.229B |
0.00 |
| Aardvark Therapeutics (AARD) |
US |
$0.226B |
0.00 |
| Rezolute (RZLT) |
US |
$0.224B |
0.00 |
| Phathom Pharmaceuticals (PHAT) |
US |
$0.219B |
0.00 |
| Amarin (AMRN) |
IE |
$0.216B |
0.00 |
| GENFIT S.A (GNFT) |
FR |
$0.215B |
0.00 |
| Solid Biosciences (SLDB) |
US |
$0.214B |
0.00 |
| Adocia (ADOCY) |
FR |
$0.213B |
0.00 |
| Nuvectis Pharma (NVCT) |
US |
$0.212B |
0.00 |
| Neurogene (NGNE) |
US |
$0.210B |
0.00 |
| Innate Pharma S.A (IPHA) |
FR |
$0.204B |
0.00 |
| Codexis (CDXS) |
US |
$0.204B |
0.00 |
| Actuate Therapeutics (ACTU) |
US |
$0.202B |
0.00 |
| Semper Paratus Acquisition (TVGN) |
US |
$0.200B |
0.00 |
| Kodiak Sciences (KOD) |
US |
$0.199B |
0.00 |
| Design Therapeutics (DSGN) |
US |
$0.199B |
0.00 |
| Ocugen (OCGN) |
US |
$0.196B |
0.00 |
| Inventiva S.A (IVA) |
FR |
$0.190B |
0.00 |
| CARGO Therapeutics (CRGX) |
US |
$0.185B |
0.00 |
| Humacyte (HUMA) |
US |
$0.185B |
0.00 |
| Tiziana Life Sciences (TLSA) |
GB |
$0.183B |
0.00 |
| Cardiff Oncology (CRDF) |
US |
$0.177B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
US |
$0.176B |
0.00 |
| Annexon (ANNX) |
US |
$0.176B |
0.00 |
| Voyager Therapeutics (VYGR) |
US |
$0.175B |
0.00 |
| TuHURA Biosciences (HURA) |
US |
$0.174B |
0.00 |
| Eledon Pharmaceuticals (ELDN) |
US |
$0.173B |
0.00 |
| Prime Medicine (PRME) |
US |
$0.171B |
0.00 |
| ProQR Therapeutics (PRQR) |
NL |
$0.169B |
0.00 |
| AC Immune (ACIU) |
CH |
$0.169B |
0.00 |
| Anika Therapeutics (ANIK) |
US |
$0.167B |
0.00 |
| Molecular Partners AG (MOLN) |
CH |
$0.166B |
0.00 |
| Adherex Technologies (FENC) |
US |
$0.164B |
0.00 |
| Inhibrx Biosciences (INBX) |
US |
$0.162B |
0.00 |
| Sangamo Therapeutics (SGMO) |
US |
$0.160B |
0.00 |
| INmune Bio (INMB) |
US |
$0.160B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
US |
$0.157B |
0.00 |
| EnGene Holdings (ENGN) |
CA |
$0.151B |
0.00 |
| Galena Biopharma (SLS) |
US |
$0.148B |
0.00 |
| BioAge Labs (BIOA) |
US |
$0.145B |
0.00 |
| Puma Biotechnology (PBYI) |
US |
$0.144B |
3.78 |
| Nkarta (NKTX) |
US |
$0.137B |
0.00 |
| Eupraxia Pharmaceuticals (EPRX) |
CA |
$0.136B |
0.00 |
| ADC Therapeutics SA (ADCT) |
CH |
$0.126B |
0.00 |
| Greenwich LifeSciences (GLSI) |
US |
$0.125B |
0.00 |
| Tango Therapeutics (TNGX) |
US |
$0.123B |
0.00 |
| ScPharmaceuticals (SCPH) |
US |
$0.123B |
0.00 |
| Editas Medicine (EDIT) |
US |
$0.121B |
0.00 |
| Theratechnologies (THTX) |
CA |
$0.120B |
0.00 |
| Fate Therapeutics (FATE) |
US |
$0.119B |
0.00 |
| Alpha Cognition (ACOG) |
CA |
$0.119B |
0.00 |
| Alector (ALEC) |
US |
$0.117B |
0.00 |
| Vigil Neuroscience (VIGL) |
US |
$0.113B |
0.00 |
| Compugen (CGEN) |
IL |
$0.112B |
0.00 |
| Coherus BioSciences (CHRS) |
US |
$0.112B |
0.00 |
| Genelux (GNLX) |
US |
$0.112B |
0.00 |
| Seer (SEER) |
US |
$0.110B |
0.00 |
| EXoZymes (EXOZ) |
US |
$0.109B |
0.00 |
| InflaRx (IFRX) |
DE |
$0.108B |
0.00 |
| Neumora Therapeutics (NMRA) |
US |
$0.107B |
0.00 |
| BioHarvest Sciences (BHST) |
CA |
$0.106B |
0.00 |
| C4 Therapeutics (CCCC) |
US |
$0.104B |
0.00 |
| Cuprina Holdings (Cayman) (CUPR) |
SG |
$0.102B |
0.00 |
| Orchestra BioMed Holdings (OBIO) |
US |
$0.102B |
0.00 |
| Coya Therapeutics (COYA) |
US |
$0.101B |
0.00 |
| Contineum Therapeutics (CTNM) |
US |
$0.100B |
0.00 |
| Sagimet Biosciences (SGMT) |
US |
$0.100B |
0.00 |
| Rapt Therapeutics (RAPT) |
US |
$0.100B |
0.00 |
| Entera Bio (ENTX) |
IL |
$0.098B |
0.00 |
| Immunic (IMUX) |
US |
$0.097B |
0.00 |
| HilleVax (HLVX) |
US |
$0.095B |
0.00 |
| Black Diamond Therapeutics (BDTX) |
US |
$0.093B |
0.00 |
| Kyverna Therapeutics (KYTX) |
US |
$0.091B |
0.00 |
| Zentalis Pharmaceuticals (ZNTL) |
US |
$0.089B |
0.00 |
| Nautilus Biotechnology (NAUT) |
US |
$0.088B |
0.00 |
| Ventyx Biosciences (VTYX) |
US |
$0.088B |
0.00 |
| Cellectis S.A (CLLS) |
FR |
$0.088B |
0.00 |
| Elicio Therapeutics (ELTX) |
US |
$0.088B |
0.00 |
| Instil Bio (TIL) |
US |
$0.087B |
0.00 |
| Pliant Therapeutics (PLRX) |
US |
$0.087B |
0.00 |
| Senti Biosciences (SNTI) |
US |
$0.085B |
0.00 |
| Elutia (ELUT) |
US |
$0.085B |
0.00 |
| XBiotech (XBIT) |
US |
$0.084B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
US |
$0.084B |
0.00 |
| Zura Bio (ZURA) |
US |
$0.083B |
0.00 |
| Climb Bio (CLYM) |
US |
$0.080B |
0.00 |
| Genenta Science S.p.A (GNTA) |
IT |
$0.079B |
0.00 |
| Invivyd (IVVD) |
US |
$0.078B |
0.00 |
| Adagene (ADAG) |
CN |
$0.075B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
GB |
$0.075B |
0.00 |
| CytomX Therapeutics (CTMX) |
US |
$0.075B |
2.44 |
| Inozyme Pharma (INZY) |
US |
$0.074B |
0.00 |
| CervoMed (CRVO) |
US |
$0.074B |
0.00 |
| Sutro Biopharma (STRO) |
US |
$0.074B |
0.00 |
| Exicure (XCUR) |
US |
$0.072B |
0.00 |
| MediciNova (MNOV) |
US |
$0.072B |
0.00 |
| Caribou Biosciences (CRBU) |
US |
$0.072B |
0.00 |
| TScan Therapeutics (TCRX) |
US |
$0.072B |
0.00 |
| I-Mab (IMAB) |
US |
$0.072B |
0.00 |
| Adlai Nortye (ANL) |
KY |
$0.068B |
0.00 |
| Jasper Therapeutics (JSPR) |
US |
$0.068B |
0.00 |
| BeyondSpring (BYSI) |
US |
$0.068B |
0.00 |
| IGM Biosciences (IGMS) |
US |
$0.068B |
0.00 |
| Clearside Biomedical (CLSD) |
US |
$0.066B |
0.00 |
| VTv Therapeutics (VTVT) |
US |
$0.066B |
0.00 |
| Inovio Pharmaceuticals (INO) |
US |
$0.066B |
0.00 |
| IO Biotech (IOBT) |
DK |
$0.066B |
0.00 |
| Prenetics Global (PRE) |
HK |
$0.066B |
0.00 |
| VistaGen Therapeutics (VTGN) |
US |
$0.065B |
0.00 |
| Medicus Pharma (MDCX) |
US |
$0.062B |
0.00 |
| Agenus (AGEN) |
US |
$0.062B |
0.00 |
| Seres Therapeutics (MCRB) |
US |
$0.062B |
0.00 |
| Biomea Fusion (BMEA) |
US |
$0.061B |
0.00 |
| Citius Oncology (CTOR) |
US |
$0.061B |
0.00 |
| ZIVO Bioscience (ZIVO) |
US |
$0.061B |
0.00 |
| Achilles Therapeutics (ACHL) |
GB |
$0.061B |
0.00 |
| Cabaletta Bio (CABA) |
US |
$0.060B |
0.00 |
| Alto Neuroscience (ANRO) |
US |
$0.060B |
0.00 |
| Acumen Pharmaceuticals (ABOS) |
US |
$0.059B |
0.00 |
| Milestone Pharmaceuticals (MIST) |
CA |
$0.059B |
0.00 |
| Adverum Biotechnologies (ADVM) |
US |
$0.059B |
0.00 |
| Repare Therapeutics (RPTX) |
CA |
$0.058B |
0.00 |
| Immix Biopharma (IMMX) |
US |
$0.058B |
0.00 |
| Applied Therapeutics (APLT) |
US |
$0.057B |
0.00 |
| Skye Bioscience, Inc. (SKYE) |
US |
$0.056B |
0.00 |
| Akoya Biosciences, Inc. (AKYA) |
US |
$0.055B |
0.00 |
| PDS Biotechnology Corporation (PDSB) |
US |
$0.055B |
0.00 |
| Ikena Oncology, Inc. (IKNA) |
US |
$0.055B |
0.00 |
| Precision BioSciences, Inc. (DTIL) |
US |
$0.054B |
0.00 |
| Cyclacel Pharmaceuticals, Inc. (CYCC) |
US |
$0.053B |
0.00 |
| Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) |
GB |
$0.052B |
0.00 |
| Artiva Biotherapeutics, Inc. (ARTV) |
US |
$0.051B |
0.00 |
| Adicet Bio, Inc. (ACET) |
US |
$0.050B |
0.00 |
| Renovaro Inc. (RENB) |
US |
$0.050B |
0.00 |
| Fortress Biotech, Inc. (FBIO) |
US |
$0.050B |
0.00 |
| PepGen, Inc. (PEPG) |
US |
$0.049B |
0.00 |
| OKYO Pharma Limited Sponsored ADR (OKYO) |
|
$0.049B |
0.00 |
| Oncobiologics, Inc. (OTLK) |
US |
$0.049B |
0.00 |
| Cue Biopharma, Inc. (CUE) |
US |
$0.048B |
0.00 |
| Shattuck Labs, Inc. (STTK) |
US |
$0.045B |
0.00 |
| Quince Therapeutics, Inc. (QNCX) |
US |
$0.045B |
0.00 |
| Oncolytics Biotech Inc. (ONCY) |
CA |
$0.045B |
0.00 |
| Connect Biopharma Holdings Limited Sponsored ADR (CNTB) |
US |
$0.045B |
0.00 |
| Pluri Inc. (PLUR) |
IL |
$0.045B |
0.00 |
| Kronos Bio, Inc. (KRON) |
US |
$0.044B |
0.00 |
| Atara Biotherapeutics, Inc. (ATRA) |
US |
$0.043B |
0.00 |
| Opus Genetics, Inc. (IRD) |
US |
$0.043B |
0.00 |
| CAMP4 Therapeutics Corporation (CAMP) |
US |
$0.043B |
0.00 |
| Lantern Pharma Inc. (LTRN) |
US |
$0.043B |
0.00 |
| Anebulo Pharmaceuticals, Inc. (ANEB) |
US |
$0.043B |
0.00 |
| TELA Bio, Inc. (TELA) |
US |
$0.043B |
0.00 |
| Alterity Therapeutics Limited - Sponsored ADR (ATHE) |
AU |
$0.043B |
0.00 |
| Forte Biosciences, Inc. (FBRX) |
US |
$0.042B |
0.00 |
| Whitehawk Therapeutics, Inc. (WHWK) |
US |
$0.042B |
0.00 |
| Rani Therapeutics Holdings, Inc. (RANI) |
US |
$0.042B |
0.00 |
| Immuneering Corporation (IMRX) |
US |
$0.041B |
0.00 |
| Celularity, Inc. (CELU) |
US |
$0.040B |
0.00 |
| Mersana Therapeutics, Inc. (MRSN) |
US |
$0.040B |
0.00 |
| Tvardi Therapeutics, Inc. (TVRD) |
US |
$0.039B |
0.00 |
| RenovoRx, Inc. (RNXT) |
US |
$0.039B |
0.00 |
| Rein Therapeutics Inc. (RNTX) |
US |
$0.039B |
0.00 |
| Estrella Immunopharma, Inc. (ESLA) |
US |
$0.037B |
0.00 |
| Xilio Therapeutics, Inc. (XLO) |
US |
$0.037B |
0.00 |
| Tenaya Therapeutics, Inc. (TNYA) |
US |
$0.036B |
0.00 |
| AN2 Therapeutics, Inc. (ANTX) |
US |
$0.036B |
0.00 |
| Werewolf Therapeutics, Inc. (HOWL) |
US |
$0.036B |
0.00 |
| Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) |
GB |
$0.035B |
0.00 |
| Spero Therapeutics, Inc. (SPRO) |
US |
$0.035B |
0.00 |
| bluebird bio, Inc. (BLUE) |
US |
$0.034B |
0.00 |
| Akari Therapeutics PLC (AKTX) |
GB |
$0.034B |
0.00 |
| LAVA Therapeutics N.V. (LVTX) |
NL |
$0.033B |
0.00 |
| Dyadic International Inc. (DYAI) |
US |
$0.032B |
0.00 |
| Boundless Bio, Inc. (BOLD) |
US |
$0.032B |
0.00 |
| Coeptis Therapeutics Holdings, Inc. (COEP) |
US |
$0.032B |
0.00 |
| FibroBiologics Inc. (FBLG) |
US |
$0.032B |
0.00 |
| Radiopharm Theranostics Limited - Sponsored ADR (RADX) |
AU |
$0.031B |
0.00 |
| Kezar Life Sciences, Inc. (KZR) |
US |
$0.031B |
0.00 |
| Allakos Inc. (ALLK) |
US |
$0.030B |
0.00 |
| Femasys Inc. (FEMY) |
US |
$0.029B |
0.00 |
| Cadrenal Therapeutics, Inc. (CVKD) |
US |
$0.028B |
0.00 |
| CalciMedica Inc. (CALC) |
US |
$0.028B |
0.00 |
| MiNK Therapeutics, Inc. (INKT) |
US |
$0.028B |
0.00 |
| Scilex Holding Company (SCLX) |
US |
$0.028B |
0.00 |
| Grace Therapeutics, Inc. (GRCE) |
CA |
$0.028B |
0.00 |
| Aligos Therapeutics, Inc. (ALGS) |
US |
$0.027B |
0.00 |
| OnKure Therapeutics, Inc. (OKUR) |
US |
$0.026B |
0.00 |
| Dare Bioscience, Inc. (DARE) |
US |
$0.026B |
0.00 |
| BioAtla, Inc. (BCAB) |
US |
$0.025B |
0.00 |
| Quantum Biopharma Ltd. (QNTM) |
CA |
$0.025B |
0.00 |
| Generation Bio Co. (GBIO) |
US |
$0.024B |
0.00 |
| Clene Inc. (CLNN) |
US |
$0.024B |
0.00 |
| Tenax Therapeutics, Inc. (TENX) |
US |
$0.023B |
0.00 |
| ALX Oncology Holdings Inc. (ALXO) |
US |
$0.023B |
0.00 |
| KALA BIO, Inc. (KALA) |
US |
$0.022B |
0.00 |
| Annovis Bio, Inc. (ANVS) |
US |
$0.022B |
0.00 |
| CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) |
IL |
$0.021B |
0.00 |
| Ovid Therapeutics (OVID) |
US |
$0.021B |
0.00 |
| Advanced Biomed Inc. (ADVB) |
US |
$0.021B |
0.00 |
| MIRA Pharmaceuticals, Inc. (MIRA) |
US |
$0.021B |
0.00 |
| Passage Bio, Inc. (PASG) |
US |
$0.020B |
0.00 |
| Elevation Oncology, Inc. (ELEV) |
US |
$0.020B |
0.00 |
| ABVC BioPharma, Inc. (ABVC) |
US |
$0.020B |
0.00 |
| Longeveron Inc. (LGVN) |
US |
$0.020B |
0.00 |
| Curis, Inc. (CRIS) |
US |
$0.020B |
0.00 |
| X4 Pharmaceuticals, Inc. (XFOR) |
US |
$0.020B |
0.00 |
| Lexaria Bioscience Corp. (LEXX) |
CA |
$0.019B |
0.00 |
| Q32 Bio Inc. (QTTB) |
US |
$0.019B |
0.00 |
| Vor Biopharma Inc. (VOR) |
|
$0.019B |
0.00 |
| Cognition Therapeutics, Inc. (CGTX) |
US |
$0.019B |
0.00 |
| Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) |
IL |
$0.018B |
0.00 |
| Lisata Therapeutics, Inc. (LSTA) |
US |
$0.018B |
0.00 |
| Allarity Therapeutics, Inc. (ALLR) |
US |
$0.018B |
0.00 |
| Kalaris Therapeutics Inc. (KLRS) |
US |
$0.018B |
0.00 |
| Aspire Biopharma Holdings, Inc. (ASBP) |
US |
$0.017B |
0.00 |
| Cingulate Inc. (CING) |
US |
$0.017B |
0.00 |
| Beyond Air, Inc. (XAIR) |
US |
$0.017B |
0.00 |
| SAB Biotherapeutics, Inc. (SABS) |
US |
$0.017B |
0.00 |
| Promis Neurosciences (PMN) |
CA |
$0.016B |
0.00 |
| UNITY Biotechnology, Inc. (UBX) |
US |
$0.016B |
0.00 |
| HOOKIPA Pharma Inc. (HOOK) |
US |
$0.016B |
0.00 |
| Moleculin Biotech, Inc. (MBRX) |
US |
$0.015B |
0.00 |
| BioCardia, Inc. (BCDA) |
US |
$0.015B |
0.00 |
| Edesa Biotech, Inc. (EDSA) |
CA |
$0.014B |
0.00 |
| IN8bio, Inc. (INAB) |
US |
$0.014B |
0.00 |
| NeuroSense Therapeutics Ltd. (NRSN) |
IL |
$0.014B |
0.00 |
| GeoVax Labs Inc. (GOVX) |
US |
$0.014B |
0.00 |
| Equillium, Inc. (EQ) |
US |
$0.014B |
0.00 |
| Leap Therapeutics, Inc. (LPTX) |
US |
$0.014B |
0.00 |
| Bolt Biotherapeutics, Inc. (BOLT) |
US |
$0.014B |
0.00 |
| Biorestorative Therapies, Inc. (BRTX) |
US |
$0.014B |
0.00 |
| Synlogic, Inc. (SYBX) |
US |
$0.013B |
0.00 |
| Gelteq Limited (GELS) |
AU |
$0.013B |
0.00 |
| iBio, Inc. (IBIO) |
US |
$0.013B |
0.00 |
| Hoth Therapeutics, Inc. (HOTH) |
US |
$0.013B |
0.00 |
| NextCure, Inc. (NXTC) |
US |
$0.013B |
0.00 |
| Rallybio Corporation (RLYB) |
US |
$0.012B |
0.00 |
| Bionano Genomics, Inc. (BNGO) |
US |
$0.012B |
0.00 |
| Imunon, Inc. (IMNN) |
US |
$0.012B |
0.00 |
| BRIACELL THERAP (BCTX) |
CA |
$0.012B |
0.00 |
| COSCIENS Biopharma Inc. (CSCI) |
CA |
$0.011B |
0.00 |
| IMMURON (IMRN) |
AU |
$0.011B |
0.00 |
| Affimed N.V. (AFMD) |
DE |
$0.011B |
0.00 |
| LakeShore Biopharma Co., Ltd. (LSB) |
CN |
$0.011B |
0.00 |
| Cyclerion Therapeutics, Inc. (CYCN) |
US |
$0.011B |
0.00 |
| Abpro Holdings Inc. (ABP) |
US |
$0.010B |
0.00 |
| Athira Pharma, Inc. (ATHA) |
US |
$0.010B |
0.00 |
| Cardio Diagnostics Holdings, Inc. (CDIO) |
US |
$0.010B |
0.00 |
| Creative Medical Technology Holdings, Inc. (CELZ) |
US |
$0.009B |
0.00 |
| Sensei Biotherapeutics, Inc. (SNSE) |
US |
$0.009B |
0.00 |
| Aprea Therapeutics, Inc. (APRE) |
US |
$0.009B |
0.00 |
| Neuphoria Therapeutics Inc. (NEUP) |
AU |
$0.009B |
0.00 |
| Dogwood Therapeutics, Inc (DWTX) |
US |
$0.009B |
0.00 |
| Portage Biotech Inc. (PRTG) |
|
$0.009B |
0.00 |
| Silexion Therapeutics Corp (SLXN) |
IL |
$0.009B |
0.00 |
| BioXcel Therapeutics, Inc. (BTAI) |
US |
$0.008B |
0.00 |
| Intensity Therapeutics Inc. (INTS) |
US |
$0.008B |
0.00 |
| Acurx Pharmaceuticals, Inc. (ACXP) |
US |
$0.008B |
0.00 |
| Turnstone Biologics Corp. (TSBX) |
US |
$0.008B |
0.00 |
| Aytu BioPharma Inc. (AYTU) |
US |
$0.008B |
0.00 |
| Brainstorm Cell Therapeutics Inc. (BCLI) |
US |
$0.008B |
0.00 |
| Jade Biosciences, Inc. (JBIO) |
US |
$0.007B |
0.00 |
| HCW Biologics Inc. (HCWB) |
US |
$0.007B |
0.00 |
| GENPREX (GNPX) |
US |
$0.007B |
0.00 |
| Biofrontera Inc. (BFRI) |
US |
$0.007B |
0.00 |
| Soligenix Inc. (SNGX) |
US |
$0.006B |
0.00 |
| Avalon GloboCare Corp. (ALBT) |
US |
$0.006B |
0.00 |
| MetaVia Inc. (MTVA) |
US |
$0.006B |
0.00 |
| Apollomics Inc. (APLM) |
US |
$0.006B |
0.00 |
| Lipella Pharmaceuticals Inc. (LIPO) |
US |
$0.006B |
0.00 |
| Evogene Ltd. (EVGN) |
IL |
$0.006B |
0.00 |
| GT Biopharma, Inc. (GTBP) |
US |
$0.006B |
0.00 |
| Mainz Biomed NV (MYNZ) |
DE |
$0.006B |
0.00 |
| 180 Life Sciences Corp. (ATNF) |
US |
$0.006B |
0.00 |
| Arcadia Biosciences, Inc. (RKDA) |
US |
$0.005B |
0.00 |
| Ensysce Biosciences, Inc. (ENSC) |
US |
$0.005B |
0.00 |
| Dermata Therapeutics, Inc. (DRMA) |
US |
$0.005B |
0.00 |
| Alzamend Neuro, Inc. (ALZN) |
US |
$0.005B |
0.00 |
| Onconetix, Inc. (ONCO) |
US |
$0.005B |
0.00 |
| Titan Pharmaceuticals, Inc. (TTNP) |
US |
$0.005B |
0.00 |
| Hepion Pharmaceuticals, Inc. (HEPA) |
US |
$0.004B |
0.00 |
| Adial Pharmaceuticals, Inc. (ADIL) |
US |
$0.004B |
0.00 |
| Sonnet BioTherapeutics Holdings, Inc. (SONN) |
US |
$0.004B |
0.00 |
| Mustang Bio, Inc. (MBIO) |
US |
$0.004B |
0.00 |
| Lixte Biotechnology Holdings, Inc. (LIXT) |
US |
$0.004B |
0.00 |
| bioAffinity Technologies, Inc. (BIAF) |
US |
$0.004B |
0.00 |
| Novogen Limited (KZIA) |
AU |
$0.004B |
0.00 |
| Silo Pharma, Inc. (SILO) |
US |
$0.004B |
0.00 |
| Galecto, Inc. (GLTO) |
DK |
$0.004B |
0.00 |
| VivoSim Labs, Inc. (VIVS) |
US |
$0.004B |
0.00 |
| Virax Biolabs Group Limited (VRAX) |
GB |
$0.003B |
0.00 |
| Sunshine Biopharma, Inc. (SBFM) |
US |
$0.003B |
0.00 |
| CNS Pharmaceuticals, Inc. (CNSP) |
US |
$0.003B |
0.00 |
| Artelo Biosciences, Inc. (ARTL) |
US |
$0.003B |
0.00 |
| Synaptogenix, Inc. (SNPX) |
US |
$0.003B |
0.00 |
| Tharimmune, Inc. (THAR) |
US |
$0.003B |
0.00 |
| Palisade Bio, Inc. (PALI) |
US |
$0.003B |
0.00 |
| Enveric Biosciences, Inc. (ENVB) |
US |
$0.003B |
0.00 |
| Windtree Therapeutics, Inc. (WINT) |
US |
$0.003B |
0.00 |
| Eyenovia, Inc. (EYEN) |
US |
$0.003B |
0.00 |
| Purple Biotech Ltd. Sponsored ADR (PPBT) |
IL |
$0.003B |
0.00 |
| Revelation Biosciences, Inc. (REVB) |
US |
$0.003B |
0.00 |
| GRI Bio, Inc. (GRI) |
US |
$0.003B |
0.00 |
| AquaBounty Technologies, Inc. (AQB) |
US |
$0.003B |
0.00 |
| Pasithea Therapeutics Corp. (KTTA) |
US |
$0.002B |
0.00 |
| Bone Biologics Corp. (BBLG) |
US |
$0.002B |
0.00 |
| Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI) |
IL |
$0.002B |
0.00 |
| Psyence Biomedical Ltd. (PBM) |
CA |
$0.002B |
0.00 |
| Aptevo Therapeutics Inc. (APVO) |
US |
$0.002B |
0.00 |
| Evaxion Biotech A/S Sponsored ADR (EVAX) |
DK |
$0.002B |
0.00 |
| Entero Therapeutics, Inc. (ENTO) |
US |
$0.002B |
0.00 |
| Atrinsic Inc. (PTIX) |
US |
$0.002B |
0.00 |
| Polyrizon Ltd. (PLRZ) |
IL |
$0.002B |
0.00 |
| ZyVersa Therapeutics, Inc. (ZVSA) |
US |
$0.001B |
0.00 |
| TFF Pharmaceuticals, Inc. (TFFP) |
US |
$0.000B |
0.00 |
| Capstone Therapeutics Corp. (CAPS) |
US |
$0.000B |
0.00 |
| NuCana PLC Sponsored ADR (NCNA) |
GB |
$0.000B |
0.00 |
| Aceragen, Inc. (ACGN) |
US |
$0.000B |
0.00 |
| ARAVIVE, INC (ARAV) |
US |
$0.000B |
0.00 |
| Clovis Oncology, Inc. (CLVSQ) |
US |
$0.000B |
0.00 |
| Cocrystal Pharma, Inc. (COCP) |
US |
$0.000B |
0.00 |
| Celyad SA (CYAD) |
BE |
$0.000B |
0.00 |
| CytoMed Therapeutics Limited (GDTC) |
SG |
$0.000B |
0.00 |
| Galapagos NV (GLPG) |
BE |
$0.000B |
0.00 |
| Motif Bio Plc (MTFB) |
GB |
$0.000B |
0.00 |
| PDL BioPharma, Inc. (PDLI) |
US |
$0.000B |
0.00 |
| Pulmatrix, Inc. (PULM) |
US |
$0.000B |
0.00 |
| VectivBio Holding AG (VECT) |
CH |
$0.000B |
0.00 |
